Advances in balloon catheter treatment of intracranial atherosclerotic stenosis in the post-SAMMPRIS era

doi:10.3877/cma.j.issn.2095-5782.2020.04.013

Abstract

Abstract:

In the post-SAMMPIRS era, simple and safe balloons are again valued. The emergence of intracranial fast-exchange balloons and drug-coated balloons has opened up new clinical ideas and injected new vitality into balloon angioplasty. In this article, we will review the classification, structure, and performance of balloon catheters, as well as the progress of balloon catheter application in the treatment of intracranial atherosclerotic stenosis.

Key words: Balloon, Intracranial atherosclerotic stenosis, SAMMPIRS

Yao Tang, Ziliang Wang, Yingkun He, Tianxiao Li, Weixing Bai, Xiaoyu Kang, Bin Xu, Yanyan He, Yao Zhao. Advances in balloon catheter treatment of intracranial atherosclerotic stenosis in the post-SAMMPRIS era[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2020, 08(04): 357-363.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2020.04.013

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2020/V08/I04/357

Figures/Tables 2

References 33

[31]	Gruber P, Garcia-Esperon C, Berberat J, et al. Neuro Elutax SV drug-eluting balloon versus Wingspan stent system in symptomatic intracranial high-grade stenosis: a single-center experience[J]. Journal of NeuroInterventional Surgery, 2018, 10(12): e32-e32.
[32]	Zhang J, Zhang X, Zhang J, et al. Drug-coated balloon dilation compared with conventional stenting angioplasty for intracranial atherosclerotic disease[J]. Neurosurgery, 2020, 87(5): 992-998.
[33]	Wang Y, Feng Y, Wang T, et al. Drug-coated balloon for vertebral artery origin stenosis: a pilot study[J]. Journal of NeuroInterventional Surgery, 2020. DOI: 10.1136/neurintsurg-2020-016723.
[1]	中国卒中学会，中国卒中学会神经介入分会，中华预防医学会卒中预防与控制专业委员会介入学组. 急性缺血性卒中血管内治疗中国指南2018[J]. 中国卒中杂志, 2018, 13(7): 706-729.
[2]	中国卒中学会，中国卒中学会神经介入分会，中华预防医学会卒中预防与控制专业委员会介入学组. 症状性颅内动脉粥样硬化性狭窄血管内治疗中国专家共识2018[J]. 中国卒中杂志, 2018, 13(6): 594-604.
[3]	Sundt TM Jr, Smith HC, Campbell JK，et al. Transluminal angioplasty for basilar artery stenosis[J]. Mayo Clin Proc, 1980, 55(11): 673-680.
[4]	Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis[J]. New England Journal of Medicine, 2011, 365(11): 993-1003.
[5]	Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect ofa balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial[J]. Jama, 2015, 313(12): 1240-1248.
[6]	Stapleton CJ, Chen YF, Shallwani H, et al. Submaximal angioplasty for symptomatic intracranial atherosclerotic disease: a meta-analysis of peri-procedural and long-term risk[J]. Neurosurgery, 2020, 86(6): 755-762.
[7]	Dumont TM, Sonig A, Mokin M, et al. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective phase I study[J]. Journal of neurosurgery, 2016, 125(4): 964-971.
[8]	Dumont TM, Kan P, Snyder KV, et al. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study[J]. Neurosurgery, 2012, 71(6): 1103-1110.
[9]	Peng G, Zhang J, Jia B, et al. Submaximal primary angioplasty for symptomatic intracranial atherosclerosis: peri-procedural complications and long-term outcomes[J]. Neuroradiology, 2019, 61(1): 97-102.
[10]	Wang Y, Ma Y, Gao P, et al. Primary angioplasty without stenting for symptomatic, high-grade intracranial stenosis with poor circulation[J]. American Journal of Neuroradiology, 2018, 39(8): 1487-1492.
[11]	Sarfo FS, Ulasavets U, Opare-Sem OK, et al. Tele-rehabilitation after stroke: an updated systematic review of the literature[J]. Journal of Stroke and Cerebrovascular Diseases, 2018, 27(9): 2306-2318.
[12]	邓一鸣，张净瑜，孙瑄, 等. 单纯球囊扩张成形术治疗颅内动脉粥样硬化性狭窄的单中心前瞻性疗效观察[J]. 中华神经外科杂志, 2020, 36(7): 682-687.
[13]	Okada H, Terada T, Tanaka Y, et al. Reappraisal of primary balloon angioplasty without stenting for patients with symptomatic middle cerebral artery stenosis[J]. Neurologia Medico-Chirurgica, 2015, 55(2): 133-140.
[14]	吴立恒，冯广森，李天晓, 等. 应用改良预扩张球囊的Wingspan支架成形术治疗颅内动脉狭窄[J]. 中华实验外科杂志, 2016, 33(1): 229-231.
[15]	Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome[J]. Stroke, 2006, 37(4): 1016-1020.
[16]	Terada T, Higashida RT, Halbach VV, et al. Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries[J]. Journal of Neurology, Neurosurgery & Psychiatry, 1996, 60(4): 377-381.
[17]	Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization[J]. European Heart Journal, 2019, 40(2): 87-165.
[18]	《药物涂层球囊临床应用中国专家共识》专家组. 药物涂层球囊临床应用中国专家共识[J]. 中国介入心脏病学杂志, 2016, 24(2): 61-67.
[19]	Gruber P, Remonda L. Device profile of different paclitaxel-coated balloons: Neuro Elutax SV, Elutax '3’Neuro and SeQuent Please NEO for the treatment of symptomatic intracranial high-grade stenosis: overview of their feasibility and safety[J]. Expert Review of Medical Devices, 2020, 17(2): 87-92.
[20]	孔令华，贺迎坤，李天晓, 等. 镁基合金生物可降解支架的国内外研究进展[J]. 中华介入放射学电子杂志, 2020, 8(1): 83-88.
[21]	张一林，贺迎坤，李天晓, 等. 涂布介入器械的人血管内皮生长因子真核表达载体的构建[J]. 中华介入放射学电子杂志, 2019, 7(1): 40-43.
[22]	Vajda Z, Güthe T, Perez MA, et al. Neurovascular in-stent stenoses: treatment with conventional and drug-eluting balloons[J]. American Journal of Neuroradiology, 2011, 32(10): 1942-1947.
[23]	Montorsi P, Galli S, Ravagnani PM, et al. Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: preliminary report[J]. Journal of Endovascular Therapy, 2012, 19(6): 734-742.
[24]	Vajda Z, Güthe T, Perez MA, et al. Prevention of intracranial in-stent restenoses: predilatation with a drug eluting balloon, followed by the deployment of a self-expanding stent[J]. Cardiovascular and Interventional Radiology, 2013, 36(2): 346-352.
[25]	Turk AS, Levy EI, Albuquerque FC, et al. Influence of patient age and stenosis location on wingspan in-stent restenosis[J]. American Journal of Neuroradiology, 2008, 29(1): 23-27.
[26]	Vajda Z, Schmid E, Güthe T, et al. The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent[J]. Neurosurgery, 2012, 70(1): 91-101.
[27]	Gruber P, Braun C, Kahles T, et al. Percutaneous transluminal angioplasty using the novel drug-coated balloon catheter SeQuent Please NEO for the treatment of symptomatic intracranial severe stenosis: feasibility and safety study[J]. Journal of Neurointerventional Surgery, 2019, 11(7): 719-722.
[28]	Han J, Zhang J, Zhang X, et al. Drug-coated balloons for the treatment of symptomatic intracranial atherosclerosis: initial experience and follow-up outcome[J]. Journal of NeuroInterventional Surgery, 2019, 11(6): 569-573.
[29]	Remonda L, Diepers M, Berberat J, et al. Drug-coated balloon treatment in symptomatic intracranial high grade stenosis:a retrospective study of 33 patients[J]. Clinical Neuroradiology, 2020. DOI: 10.1007/s00062-020-00936-9.
[30]	Wang AYC, Chang CH, Chen CC, et al. Leave nothing behind: treatment of intracranial atherosclerotic disease with drug-coated balloon angioplasty[J]. Clinical Neuroradiology, 2020. DOI: 10.1007/s00062-020-00935-w.

商品名称	生产企业	涂层药物	载药剂量（μg/mm²）
SeQuent Please	B.Braun	紫杉醇-碘普罗胺	3
Dior Ⅰ/Dior Ⅱ	Eurocor GmbH	紫杉醇/紫杉醇-虫胶	3
In. Pact Falcon	Medtronic	紫杉醇-尿素	3.5
Pantera Lux	Biotronik	紫杉醇-丁酰柠檬酸三正己酯	3
Cotavance	Medrad	紫杉醇	3
Lutonix^®	Lutonix	紫杉醇-聚山梨酯醇和山黎醇	2
Ranger	Bonston Scientific	紫杉醇-丁酰柠檬酸三正己酯	2
In.Pact Admiral	Medtronic	紫杉醇-尿素	3.5
Stellarex	Philips	紫杉醇-PEG 8000	2
Elutax SV	Aachen Resonance	紫杉醇	3
Elutax '3’Neuro	AR Baltic Medical	葡聚糖-紫杉醇	3
SeQuent Please NEO	B.Braun	紫杉醇-碘普罗胺	3
先瑞达	Orchid,Dhalia	紫杉醇-硬酯酸镁	3.3
微创心脉	Reewarm-PTX	紫杉醇-碘普罗胺	3
垠艺生物	Bingo	紫杉醇-碘海醇	3

商品名称	生产企业	涂层药物	载药剂量（μg/mm²）
SeQuent Please	B.Braun	紫杉醇-碘普罗胺	3
Dior Ⅰ/Dior Ⅱ	Eurocor GmbH	紫杉醇/紫杉醇-虫胶	3
In. Pact Falcon	Medtronic	紫杉醇-尿素	3.5
Pantera Lux	Biotronik	紫杉醇-丁酰柠檬酸三正己酯	3
Cotavance	Medrad	紫杉醇	3
Lutonix^®	Lutonix	紫杉醇-聚山梨酯醇和山黎醇	2
Ranger	Bonston Scientific	紫杉醇-丁酰柠檬酸三正己酯	2
In.Pact Admiral	Medtronic	紫杉醇-尿素	3.5
Stellarex	Philips	紫杉醇-PEG 8000	2
Elutax SV	Aachen Resonance	紫杉醇	3
Elutax '3’Neuro	AR Baltic Medical	葡聚糖-紫杉醇	3
SeQuent Please NEO	B.Braun	紫杉醇-碘普罗胺	3
先瑞达	Orchid,Dhalia	紫杉醇-硬酯酸镁	3.3
微创心脉	Reewarm-PTX	紫杉醇-碘普罗胺	3
垠艺生物	Bingo	紫杉醇-碘海醇	3

文献	发表时间	手术方式	病变数量	病变位置（数量）	预扩张	球囊大小（mm）	术后残余狭窄（%）	临床并发症 [例(%)]	亚临床并发症 [例(%)]	随访时间（月）	再狭窄发生率（%）
Guber等^[27]	2018年10月	SeQuent Please NEO	10	VA颅内段（4），BA（2），ICA颅内段（4）	否	亚满意成形	50(45～53)	0	0	3	0
Han等^[28]	2018年10月	SeQuent Please	31	MCA（12），BA（17），VA颅内段（2）	是	正常血管直径0.8～1.0	20(10～40)	2(6.5%)	0	9.8	3.5%
Remonda等^[29]	2020年6月	Neuro Elutax SV或SeQuent Please NEO	35	VA颅内段（10），BA（10），ICA颅内段（9），MAC（6）	否	亚满意成形	50(33～60)	2(6%)	0	9	15%
Wang AYC等^[30]	2020年7月	SeQuent Please	39	ICA床突段（8），ICA海绵窦段（3），MCA M1段（7），MCA M2段（1），BA（10），VA（10）	是	亚满意成形	32.4(6～60)	2(5.7%)	2(5.7%)	20.9 ±9.8	8.3%
Gruber等^[31]	2018年3月	Elutax SV vs Wingspan	8 vs 11	[MCA（3），VA（3），BA（2）] vs [ICA（1），MCA（5），VA（3），BA（2）]	否	亚满意成形	37.5(20~60) vs 10(10~50)	0 vs 6(55%)	0	3 vs 4	13% vs 55%
Zhang等^[32]	2020年3月	SeQuent Please vs支架	38 vs 38	[前循环（19），后循环（19）] vs [前循环（17），后循环（21）]	是	正常血管直径0.8～1.0	5.0(0～20.0)vs 0(0～20.0)	1(2.6%) vs 4(10.5%)	0	6	5.3% vs 34.2%

文献	发表时间	手术方式	病变数量	病变位置（数量）	预扩张	球囊大小（mm）	术后残余狭窄（%）	临床并发症 [例(%)]	亚临床并发症 [例(%)]	随访时间（月）	再狭窄发生率（%）
Guber等^[27]	2018年10月	SeQuent Please NEO	10	VA颅内段（4），BA（2），ICA颅内段（4）	否	亚满意成形	50(45～53)	0	0	3	0
Han等^[28]	2018年10月	SeQuent Please	31	MCA（12），BA（17），VA颅内段（2）	是	正常血管直径0.8～1.0	20(10～40)	2(6.5%)	0	9.8	3.5%
Remonda等^[29]	2020年6月	Neuro Elutax SV或SeQuent Please NEO	35	VA颅内段（10），BA（10），ICA颅内段（9），MAC（6）	否	亚满意成形	50(33～60)	2(6%)	0	9	15%
Wang AYC等^[30]	2020年7月	SeQuent Please	39	ICA床突段（8），ICA海绵窦段（3），MCA M1段（7），MCA M2段（1），BA（10），VA（10）	是	亚满意成形	32.4(6～60)	2(5.7%)	2(5.7%)	20.9 ±9.8	8.3%
Gruber等^[31]	2018年3月	Elutax SV vs Wingspan	8 vs 11	[MCA（3），VA（3），BA（2）] vs [ICA（1），MCA（5），VA（3），BA（2）]	否	亚满意成形	37.5(20~60) vs 10(10~50)	0 vs 6(55%)	0	3 vs 4	13% vs 55%
Zhang等^[32]	2020年3月	SeQuent Please vs支架	38 vs 38	[前循环（19），后循环（19）] vs [前循环（17），后循环（21）]	是	正常血管直径0.8～1.0	5.0(0～20.0)vs 0(0～20.0)	1(2.6%) vs 4(10.5%)	0	6	5.3% vs 34.2%

Please choose a citation manager

Content to export